Literature DB >> 22222438

Beta3 adrenoceptors substitute the role of M(2) muscarinic receptor in coping with cold stress in the heart: evidence from M(2)KO mice.

Jan Benes1, Martina Novakova, Jana Rotkova, Vladimir Farar, Richard Kvetnansky, Vladimir Riljak, Jaromir Myslivecek.   

Abstract

We investigated the role of beta3-adrenoceptors (AR) in cold stress (1 or 7 days in cold) in animals lacking main cardioinhibitive receptors-M2 muscarinic receptors (M(2)KO). There was no change in receptor number in the right ventricles. In the left ventricles, there was decrease in binding to all cardiostimulative receptors (beta1-, and beta2-AR) and increase in cardiodepressive receptors (beta3-AR) in unstressed KO in comparison to WT. The cold stress in WT animals resulted in decrease in binding to beta1- and beta2-AR (to 37%/35% after 1 day in cold and to 27%/28% after 7 days in cold) while beta3-AR were increased (to 216% of control) when 7 days cold was applied. MR were reduced to 46% and 58%, respectively. Gene expression of M2 MR in WT was not changed due to stress, while M3 was changed. The reaction of beta1- and beta2-AR (binding) to cold was similar in KO and WT animals, and beta3-AR in stressed KO animals did not change. Adenylyl cyclase activity was affected by beta3-agonist CL316243 in cold stressed WT animals but CL316243 had almost no effects on adenylyl cyclase activity in stressed KO. Nitric oxide activity (NOS) was not affected by BRL37344 (beta3-agonist) both in WT and KO animals. Similarly, the stress had no effects on NOS activity in WT animals and in KO animals. We conclude that the function of M2 MR is substituted by beta3-AR and that these effects are mediated via adenylyl cyclase rather than NOS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222438     DOI: 10.1007/s10571-011-9781-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  39 in total

1.  Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.

Authors:  J Gomeza; L Zhang; E Kostenis; C C Felder; F P Bymaster; J Brodkin; H Shannon; B Xia; A Duttaroy; C X Deng; J Wess
Journal:  Life Sci       Date:  2001-04-27       Impact factor: 5.037

2.  Activation of β3-adrenergic receptor inhibits ventricular arrhythmia in heart failure through calcium handling.

Authors:  Haitao Li; Yu Liu; He Huang; Yanhong Tang; Bo Yang; Congxin Huang
Journal:  Tohoku J Exp Med       Date:  2010-11       Impact factor: 1.848

3.  Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct.

Authors:  Jason D Hoffert; Chung-Lin Chou; Robert A Fenton; Mark A Knepper
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

4.  Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine.

Authors:  R De Matteis; J R S Arch; M L Petroni; D Ferrari; S Cinti; M J Stock
Journal:  Int J Obes Relat Metab Disord       Date:  2002-11

Review 5.  Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.

Authors:  An L Moens; Ronghua Yang; Vabren L Watts; Lili A Barouch
Journal:  J Mol Cell Cardiol       Date:  2010-02-23       Impact factor: 5.000

6.  The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase.

Authors:  A Chesley; M S Lundberg; T Asai; R P Xiao; S Ohtani; E G Lakatta; M T Crow
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

7.  Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists.

Authors:  C Gauthier; G Tavernier; J N Trochu; V Leblais; K Laurent; D Langin; D Escande; H Le Marec
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

Review 8.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.

Authors:  Jürgen Wess; Richard M Eglen; Dinesh Gautam
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

Review 9.  Adrenergic and calcium modulation of the heart in stress: from molecular biology to function.

Authors:  O Krizanova; J Myslivecek; A Tillinger; D Jurkovicova; L Kubovcakova
Journal:  Stress       Date:  2007-06       Impact factor: 3.493

10.  Heterologous regulation of muscarinic and beta-adrenergic receptors in rat cardiomyocytes in culture.

Authors:  J Myslivecek; V Lisá; S Trojan; S Tucek
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

View more
  5 in total

1.  Corticotropin-releasing hormone affects short immobilization stress-induced changes in lung cytosolic and membrane glucocorticoid binding sites.

Authors:  Jan Benes; Hana Tomankova; Martina Novakova; Zdeněk Rohan; Richard Kvetnansky; Jaromir Myslivecek
Journal:  Cell Mol Neurobiol       Date:  2013-02-21       Impact factor: 5.046

2.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

Review 3.  Role of Beta-adrenergic Receptors and Sirtuin Signaling in the Heart During Aging, Heart Failure, and Adaptation to Stress.

Authors:  Regina Celia Spadari; Claudia Cavadas; Ana Elisa T Saturi de Carvalho; Daniela Ortolani; Andre Luiz de Moura; Paula Frizera Vassalo
Journal:  Cell Mol Neurobiol       Date:  2017-10-24       Impact factor: 5.046

4.  Acute restraint stress modifies the heart rate biorhythm in the poststress period.

Authors:  Eva Varejkova; Katerina Janisova; Jaromir Myslivecek
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

Review 5.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.